Far Too Chaotic To Handle Gemcitabine?

Hyperbilirubinemia in the context of hepatic AL amyloid confers a particularly poor prognosis of http://www.selleckchem.com/products/Gemcitabine-Hydrochloride(Gemzar).html to die from their disease. Furthermore, http://www.selleck.cn/products/azd9291.html patients with advanced cardiac and hepatic involvement are usually too unwell at presentation to tolerate the doses of chemotherapy that are required to successfully suppress their underlying clonal disease. The role of solid organ transplantation in AL amyloidosis is contentious due to shortage of donor organs. Previous small series have shown inferior outcomes with heart (10) and kidney transplantation among patients with AL amyloidosis compared to those with other causes of cardiac and renal failure, respectively. Deaths have been associated with both recurrence of amyloid in the graft or progressive deposition of amyloid in nontransplanted organs. We present here the clinical management and outcome in 45 patients with AL amyloidosis attending a single national center over a 25-year http://www.selleckchem.com/products/birinapant-tl32711.html period who were selected to receive solid organ transplants, and highlight in particular, the disease- and treatment-related factors that are likely to influence outcome with solid organ transplantation during the modern era of effective chemotherapy. All patients who underwent renal, cardiac or liver transplantation for organ failure secondary to AL amyloidosis between 1984 and 2009 were identified from the UK National Amyloidosis Centre (NAC) database. Only patients without multiple myeloma underlying their AL amyloidosis received solid organ transplants. In addition, selection criteria for renal and cardiac transplantation included absence of extensive disease outside the failing organ. A good ECOG performance status was required for renal transplantation in contrast to cardiac transplantation, where performance status prior to the procedure was poor. Patients who underwent orthotopic liver transplantation (OLT) were those with a poor prognosis due to extensive liver amyloid associated with clinical decompensation. Among 2272 patients with systemic AL amyloidosis followed up in our center during the 25-year period, the 45 (2.